• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on the signal transduction passways through IL-12 receptor

Research Project

Project/Area Number 14570285
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Immunology
Research InstitutionTokyo Medical University

Principal Investigator

YOSHIMOTO Takayuki  Tokyo Medical University, Medicine, Associate Professor, 医学部, 助教授 (80202406)

Co-Investigator(Kenkyū-buntansha) MIZUGUCHI Junichiro  Tokyo Medical University, Medicine, Professor, 医学部, 教授 (20150188)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2002: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsIL-12 Receptorβ1 / Sphingosine Kinase 2 / IFN-γ Production / Proliferation / IL-27 / STAT1 / STAT3 / IL-12 / IFN-γ / 抗腫瘍効果 / CD8+T細胞 / Yeast Two-Hybrid
Research Abstract

We performed a yeast two-hybrid screening and identified the mouse sphingosine kinase 2 (SPHK2) as a molecule associating with mouse IL-12Rβ1 cytoplasmic region. Analyses on various mutants of each molecule revealed that the region including proline-rich domain in SPHK2 is likely to be responsible for the binding to IL-12Rβ1, while the regions including the carboxyl terminus and Box II in IL-12Rβ1 cytoplasmic region appear to be involved in the binding to SPHK2. Transient expression of wild-type SPHK2 in T cell hybridoma augmented IL-12-induced STAT4-mediated transcriptional activation. Ectopic expression of dominant-negative SPHK2 in Th1 cell clone significantly reduced IL-12-induced IFN-γ production, while that of wild-type SPHK2 enhanced it. In contrast, the expression minimally affected IL-12-induced proliferation. Similar decrease in IL-12-induced IFN-γ production was observed when dominant-negative SPHK2 was expressed in activated primary T cells by using a retroviral expression system. These results suggest that SPHK2 associates with IL-12Rβ1 cytoplasmic region and is likely to play a role in modulating IL-12 signaling. We also investigated the JAK/STAT signaling molecules activated by IL-27 and the role of STAT1 in IL-27-mediated responses using STAT1-deficient mice. We found that IL-27 activated JAK1, -2 TYK2, STAT1,-2,-3, and -5 in naive CD4+ T cells. Comparable proliferative response to IL-27 was observed between STAT1-deficient and wild-type naive CD4+ T cells. In contrast, IL-27 failed to induce T-bet arid IL-12Rβ2 expression, and synergistic IFN-γ production by IL-27 and IL-12 was also impaired in STAT1-deficient naive CD4+ T cells. These results suggest that IL-27 activates JAK1,-2, TYK2, STAT1, -2,-3, and -5 in naive CD4+ T cells and that STAT1 plays an indispensable role in IL-27-induced T-bet and IL-12Rβ2 expression but not proliferation.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (27 results)

All Other

All Publications (27 results)

  • [Publications] T.Yoshimoto et al.: "Positive Modulation of IL-12 Signaling by Sphingosine Kinase 2 Associating with IL-12Rβ1 Cytoplasmic Region."J.Immunol.. 171. 1352-1359 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] M.Hisada et al.: "Potent anti-tumor activity of interleukin-27."Cancer Res.. 64. 1152-1156 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] M.Hisada et al.: "Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT."Cancer Gene Therapy. in press.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] M.Shimizu et al.: "Modification of tumor cells with Fas(CD95)antigen gene and Fas ligand(CD95L)gene transfection by electroporation for immunotherapy of cancer."Mol.Biotechnol.. 25. 79-87 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] D.Nakayama et al.: "Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice."Obes Res.. 11. 87-94 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] H.Toyota et al.: "Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax."Cancer Lett.. 189. 221-230 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] H.Miyaji: "Molecular cloning and characterization of the mouse thymocyte protein gene."Gene. 297. 189-196 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] H.Toyota: "Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax."Cancer Lett.. 189. 221-230 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] D.Nakayama: "Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice."Obes Res.. 11. 87-94 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Y.Aramaki: "Efficient gene transfer to hepatoblastoma cells through asialoglycoprotein recepotr and expression under the control of the cyclin A promoter."Biol.Pharm.Bull.. 26. 357-360 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] T.Yoshimoto: "Positive Modulation of IL-12 Signaling by Sphingosine Kinase 2 Associating with IL-12Rβ1 Cytoplasmic Region."J.Immunol.. 171. 1352-1359 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] H.Suzuki: "Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells."Anticancer Res.. 23. 3247-3254 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] X.Z.Jiang: "Modulation of mThy28 nuclear protein expression during thymocyte development."Tissue Cell. 35. 471-478 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] X.Z.Jiang: "Anti-IgM-induced down-regulation of nuclear Thy28 protein expression in Ramos B lymphoma cells."Apoptosis. 8. 509-519 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] M.Shimizu: "Modification of tumor cells with Fas (CD95) antigen gene and Fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer."Mol.Biotechnol.. 25. 79-87 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] M.Hisada: "Potent anti-tumor activity of interleukin-27."Cancer Res.. 64. 1152-1156

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] M.Hisada: "Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT."Cancer Gene Therapy. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] T.Yoshimoto et al.: "Positive Modulation of IL-12 Signaling by Sphingosine Kinase 2 Associating with IL-12Rβ1 Cytoplasmic Region."J.Immunol.. 171. 1352-1359 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] M.Hisada et al.: "Potent anti-tumor activity of interleukin-27."Cancer Res.. 64. 1152-1156 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] M.Hisada et al.: "Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT."Cancer Gene Therapy. in press.

    • Related Report
      2003 Annual Research Report
  • [Publications] M.Shimizu et al.: "Modification of tumor cells with Fas (CD95) antigen gene and Fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer."Mol.Biotechnol.. 25. 79-87 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] D.Nakayama et al.: "Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice."Obes Res.. 11. 87-94 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] H.Suzuki et al.: "Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co- operatively induce apoptotic cell death in both sarcoma and myeloma cells."Anticancer Res.. 23. 3247-3254 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] H.JMiyaji, et al.: "Molecular cloning and characterization of the mouse thymocyte protein gene"Gene. 297. 189-196 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] H.Toyota, et al.: "Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax"Cancer Lett.. 189. 221-230 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] D.Nakayama, et al.: "Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice"Obes Res.. 11. 87-94 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Y.Aramakik, et al.: "Efficient gene transfer to hepatoblastoma cells through asialoglycoprotein receptor and expression under the control of the cyclin A promoter"Biol. Pharm. Bull.. (in press). (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi